MOLLY HULSEN: Open Payments
NPI 1023529468 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 18 payments from 9 companies in 2025. Trend: 2023 $761 · 2024 $466 · 2025 $592
Food & beverage: $522Education: $70
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $164 |
| Abbott Laboratories | 2 | $130 |
| Actelion Pharmaceuticals US, Inc. | 4 | $127 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $49 |
| Novo Nordisk Inc | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: WATCHMAN FLX, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, OPSUMIT, UPTRAVI, LifeVest, Wegovy, MITRACLIP, LEQVIO.
Industry payments across MO — which companies pay providers there.
